ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,379.40
-1.79%
S&P ASX All Technology
3,901.70
-2.06%
Brent Oil
76.845
0.64%
US Dollar vs AUD
1.62507
-0.15%
Bitcoin
94,885.41
-2.88%
Pepperstone
Advertisement
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. USOTC

  6. Sorrento Therapeutics Inc (CE) (SRNE) Share Price

Sorrento Therapeutics Inc (CE)

Sorrento Therapeutics Inc (CE) (SRNE)

USOTC
0.0004
0.00
(0.00%)
Closed 03 February 8:00AM
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
0.0004
Bid
0.00
Offer
0.00
Volume
-
0.00 Day's Range 0.00
0.0001 52 Week Range 0.0925
Previous Close
0.0004
Open
-
Last Trade
Last Trade Time
Average Volume (3m)
302,821
Financial Volume
-
VWAP
-

Ask ADVFN Intelligence (AI)

SRNE Latest News

More News

Sorrento Therapeutics Announces Full Exercise of Over-Allotment Option

Sorrento Therapeutics Announces Full Exercise of Over-Allotment Option PR Newswire SAN DIEGO, Oct. 25, 2013 SAN DIEGO, Oct. 25, 2013 /PRNewswire/ -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE...

26 October 2013
PR Newswire (US)

Venue Change

Fri, Oct 25, 2013 12:00 - Sorrento Therapeutics, Inc. (SRNE: Nasdaq) - Venue Change - The symbol, SRNE, no longer trades on OTC Link. As of Fri, Oct 25, 2013, SRNE trades on Nasdaq. You may find...

25 October 2013
OTC Markets

Sorrento Therapeutics Acquires Clinical Stage Drug Candidate for Treatment of Chronic Pain

Sorrento Therapeutics Acquires Clinical Stage Drug Candidate for Treatment of Chronic Pain PR Newswire SAN DIEGO, Oct. 10, 2013 SAN DIEGO, Oct. 10, 2013 /PRNewswire/ -- Sorrento Therapeutics...

11 October 2013
PR Newswire (US)

Sorrento Therapeutics Announces a Presentation on Cynviloq™ at the AACR Conference on Advances in Ovarian Cancer Research: ...

Sorrento Therapeutics Announces a Presentation on Cynviloq™ at the AACR Conference on Advances in Ovarian Cancer Research: From Concept to Clinic PR Newswire SAN DIEGO, Sept. 16, 2013 SAN DIEGO...

16 September 2013
PR Newswire (US)

Sorrento Therapeutics Secures Rights to Biomiga Diagnostics' Therapeutic Drug Monitoring Device for Development of Personaliz...

Sorrento Therapeutics Secures Rights to Biomiga Diagnostics' Therapeutic Drug Monitoring Device for Development of Personalized Paclitaxel Cancer Therapy PR Newswire SAN DIEGO, Sept. 10, 2013 SAN...

10 September 2013
PR Newswire (US)

Sorrento Therapeutics Completes IgDraSol Merger

Sorrento Therapeutics Completes IgDraSol Merger PR Newswire SAN DIEGO, Sept. 10, 2013 SAN DIEGO, Sept. 10, 2013 /PRNewswire/ -- Sorrento Therapeutics, Inc. (OTC QB: SRNE; Sorrento) announced...

10 September 2013
PR Newswire (US)

Sorrento Therapeutics and IGDRASOL Proceed with Development of Cynviloq™ under 505(b)(2) Bioequivalence Regulatory Pathway

Sorrento Therapeutics and IGDRASOL Proceed with Development of Cynviloq™ under 505(b)(2) Bioequivalence Regulatory Pathway Official Minutes from End-of-Phase 2 FDA Meeting Provide Clarity on Next...

05 August 2013
PR Newswire (US)

Sorrento Therapeutics Announces Reverse Split of Common Stock

Sorrento Therapeutics Announces Reverse Split of Common Stock PR Newswire SAN DIEGO, Aug. 1, 2013 SAN DIEGO, Aug. 1, 2013 /PRNewswire/ -- Sorrento Therapeutics, Inc. (OTCQB: SRNE; Sorrento...

01 August 2013
PR Newswire (US)

Sorrento Therapeutics, Inc. and IGDRASOL Will Present Preliminary Phase III Data Analysis for Cynviloq at the 4th Internation...

Sorrento Therapeutics, Inc. and IGDRASOL Will Present Preliminary Phase III Data Analysis for Cynviloq at the 4th International Nanomedicine Conference in Sydney, Australia PR Newswire SAN DIEGO...

01 July 2013
PR Newswire (US)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.0001-200.00050.0050.0001822100.00041333CS
4000.00040.0050.0001654280.00047668CS
12-0.0025-86.20689655170.00290.0140.00013028210.00140497CS
26-0.0001-200.00050.09250.00012350380.00303755CS
52-0.0156-97.50.0160.09250.00011957980.00646251CS
156-7.8596-99.99491094157.867.860.00011910460.00646251CS
260-7.8596-99.99491094157.867.860.00011856390.00646251CS

SRNE - Frequently Asked Questions (FAQ)

What is the current Sorrento Therapeutics (CE) share price?
The current share price of Sorrento Therapeutics (CE) is US$ 0.0004
What is the 1 year trading range for Sorrento Therapeutics (CE) share price?
Sorrento Therapeutics (CE) has traded in the range of US$ 0.0001 to US$ 0.0925 during the past year

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AABVFAberdeen International Inc (PK)
US$ 0.015
(0.00%)
0
AABKFAareal Bank AG (CE)
US$ 0.00
(0.00%)
0
AABBAsia Broadband Inc (PK)
US$ 0.0258
(0.00%)
0
AAALYAareal Bank AG (PK)
US$ 34.65
(0.00%)
0
AAAIFAlternative Investment Trust (PK)
US$ 0.55
(0.00%)
0
AABVFAberdeen International Inc (PK)
US$ 0.015
(0.00%)
0
AABKFAareal Bank AG (CE)
US$ 0.00
(0.00%)
0
AABBAsia Broadband Inc (PK)
US$ 0.0258
(0.00%)
0
AAALYAareal Bank AG (PK)
US$ 34.65
(0.00%)
0
AAAIFAlternative Investment Trust (PK)
US$ 0.55
(0.00%)
0
AABVFAberdeen International Inc (PK)
US$ 0.015
(0.00%)
0
AABKFAareal Bank AG (CE)
US$ 0.00
(0.00%)
0
AABBAsia Broadband Inc (PK)
US$ 0.0258
(0.00%)
0
AAALYAareal Bank AG (PK)
US$ 34.65
(0.00%)
0
AAAIFAlternative Investment Trust (PK)
US$ 0.55
(0.00%)
0

Discussion

View Full Feed
ToddM ToddM 3 minutes ago
Check out the updated share count..it's so embarrassing I don't even want to post it. Trash company. I took my losses 
RONN
saigai saigai 3 minutes ago
ldtc waiting to see what the mkt makes of this
https://investors.leddartech.com/English/news/news-details/2025/LeddarTech-Enters-Into-Amendments-to-Credit-Facility-and-Bridge-Financing-Offer/default.aspx
tw0122 tw0122 3 minutes ago
BCTX $5.90 + 16% 20m floater but news is decent..

BCTX
TrendTrade2016 TrendTrade2016 4 minutes ago
BCTX POST SPLIT RUN UNDERWAY
BCTX
k9narc k9narc 4 minutes ago
There is no "high road" in trumps swamp.
$PennyMover $PennyMover 4 minutes ago
GM folks
GRLF
BlazingStocks BlazingStocks 5 minutes ago
$COEP News January 31, 2025
Coeptis Therapeutics Holdings, Inc. (COEP): Pioneering AI-Powered Marketing for Healthcare Innovation
https://finance.yahoo.com/news/coeptis-therapeutics-holdings-inc-coep-151215721.html
COEP
georgie18 georgie18 5 minutes ago
Nice news...🥳
SHEEPWOLF SHEEPWOLF 5 minutes ago
$ILLR: #Triller Apple and Google removed #TikTok from app stores on 01/19/2025
• #TikTok WILL GO DARK SOON
•$400B industry- #Triller ready to eat up market share
•this is just the beginning.🥚

https://youtu.be/gKy2CKBI09Y?si=gixUNWAt2X-v635T
ILLR
glenn1919 glenn1919 5 minutes ago
MGOL......IVVD.......MULN...................................https://stockcharts.com/h-sc/ui?s=MULN&p=D&yr=0&mn=3&dy=0&id=p11960084343
IVVD MGOL MULN
SHEEPWOLF SHEEPWOLF 5 minutes ago
$ILLR: #Triller Apple and Google removed #TikTok from app stores on 01/19/2025
• #TikTok WILL GO DARK SOON
•$400B industry- #Triller ready to eat up market share
•this is just the beginning.🥚

https://youtu.be/gKy2CKBI09Y?si=gixUNWAt2X-v635T
ILLR
MightyX MightyX 5 minutes ago
Y’all lost shareprice-control to expert market..but maintain communication-control…no pitty-points.
TPTW
Mark Mark 5 minutes ago
$UOKA got a nice pump to .42 this morning.
UOKA
saigai saigai 5 minutes ago
https://investors.leddartech.com/English/news/news-details/2025/LeddarTech-Enters-Into-Amendments-to-Credit-Facility-and-Bridge-Financing-Offer/default.aspx
LDTC
jbsliverer jbsliverer 6 minutes ago
SEC's Republican-led commission tightens oversight of probes, sources say
By Chris Prentice
February 3, 20254:00 AM MSTUpdated 2 hours ago
https://www.reuters.com/world/us/secs-republican-led-commission-tightens-oversight-probes-sources-say-2025-02-02/

SEC lawyers
Invest-in-America Invest-in-America 6 minutes ago
UOKA: Did you grab it???
UOKA
tw0122 tw0122 6 minutes ago
ICU $2.41 +'7% ...Lookong good run to $3.50s coming sooner or later .
ICU
AMB67 AMB67 7 minutes ago
It is very much a possibility.

Hopefully no more FDA comments to address, processes to validate, or tests to conduct.
RDGL
marcis marcis 7 minutes ago
Go back to Sharp and miss the run like you did there
But he is known to never have nothing real but his minions love him for that

Why post?
RDAR
bb8675309 bb8675309 7 minutes ago
Why do you clog up this message board everyday?
AVXL
glenn1919 glenn1919 7 minutes ago
UOKA......IVVD.......CGBS......PRPH........MULN...........................https://stockcharts.com/h-sc/ui?s=MULN&p=D&yr=0&mn=3&dy=0&id=p11960084343
CGBS IVVD MULN
dewophile dewophile 8 minutes ago
S-337395 PCR vs culture data

per Shionogi IR: "We have also assessed it [viral loads] using viral culture, and the results are nearly identical"
ENTA
BlazingStocks BlazingStocks 11 minutes ago
$BURU News January 23, 2025
Notice of Regaining Compliance with the NYSE
https://finance.yahoo.com/news/notice-regaining-compliance-nyse-133000496.html

BURU
AMB67 AMB67 11 minutes ago
Speak for yourself. Also, you should sell your supposed 1.5M position.
RDGL

Your Recent History

USOTC
SRNE
Sorrento Therapeutics (CE)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads